Overproduction of Chromosomal ampC β-Lactamase Gene Maintains Resistance to Cefazolin in Escherichia coli Isolates

ABSTRACT Cefazolin, an active in vitro agent against Escherichia coli, is used to treat urinary and biliary tract infections. Cefazolin is used widely as an antibiotic, and the increase in the emergence of cefazolin-resistant E. coli in many countries is a major concern. We investigated the changes...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Masato Kawamura, Ryota Ito, Yurina Tamura, Mio Takahashi, Miho Umenai, Yuriko Chiba, Takumi Sato, Shigeru Fujimura
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology 2022-06-01
Sarja:	Microbiology Spectrum
Aiheet:	cefazolin Escherichia coli acquired resistance chromosomal-ampC
Linkit:	https://journals.asm.org/doi/10.1128/spectrum.00058-22
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!